Klaus H. Metzeler

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Digital Surveillance After Allogeneic Hematopoietic Stem Cell Transplantation Guides Therapeutic Interventions to Reduce Non‐Relapse Mortality

  European Journal Of Haematology · 2026-03-18

• Nationwide analysis of acute promyelocytic leukemia: incidence and patient outcomes in Germany

  Haematologica · 2026-02-26

• MyCARdiac score: integrating cardiac imaging and biomarkers to predict outcomes in RRMM patients receiving cilta-cel

  Leukemia · 2026-02-17

• The Induction Regimen Does Not Affect Stem-Cell Collection in Adult Patients with Ewing Sarcoma

  Transfusion Medicine and Hemotherapy · 2026-02-16

• Prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemia

  Leukemia · 2026-02-09

• Associations between CT Radiomics Analyses and Hematopoietic Cell Mobilization in Patients with Multiple Myeloma: An Exploratory Analysis

  Transfusion Medicine and Hemotherapy · 2026-01-19

• Prähabilitation vor einer allogenen Blutstammzelltransplantation bei hämatologischen Neoplasien

  Die Onkologie · 2026-01-14

• Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia – a HARMONY study

  Leukemia · 2026-01-14 · 4 citations

• Who Am I? Eyebrow Follicles Minimize Donor-Derived DNA for Germline Testing After Hematopoietic Stem Cell Transplantation

  International Journal of Molecular Sciences · 2026-01-12

• Associations between CT Radiomics Analyses and Hematopoietic Cell Mobilization in Patients with Multiple Myeloma: An Exploratory Analysis

  Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V · 2026-01-01

• A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myeloma

  Cancer Cell · 2025-12-04 · 8 citations

• The sequence of 12 Gy total body irradiation and cyclophosphamide does not impact outcomes in AML patients receiving myeloablative allogeneic stem cell transplantation

  Bone Marrow Transplantation · 2025-12-02

• Spatiotemporal and genetic tracking of long-term persisting CAR-T cells following ciltacabtagene autoleucel treatment for multiple myeloma reveals molecular insights into late-onset toxicities

  Blood · 2025-11-03 · 1 citations

• Impact of Renal Impairment and Lymphodepletion Regimen on Outcomes after CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma

  Transplantation and Cellular Therapy · 2025-11-03

• Venetoclax combined with five days of azacitidine for the treatment of previously untreated Acute Myeloid Leukemia (AML): Initial results of the prospective venaza-5S trial

  Blood · 2025-11-03

• The presence of SH2B3 mutations identifies a distinct subtype of myelodysplastic neoplasms

  Blood · 2025-11-03

• MPN with multiple driver clones show distinct patterns of therapy response and progression - “MPN double driver”

  Blood · 2025-11-03 · 2 citations

• Single versus double “7+3” induction with 60 versus 90 mg/m2 daunorubicin in newly diagnosed AML: Does it matter for NPM1 MRD?

  Blood · 2025-11-03

• Independent, international validation of the unsupervised harmony classification of Acute Myeloid Leukemia

  Blood · 2025-11-03

• Validation of measurable residual disease as a surrogate endpoint in acute myeloid leukemia: A HARMONY Alliance study of European randomized trials

  Blood · 2025-11-03 · 3 citations